{"version":"1.0","provider_name":"Enago Academy","provider_url":"https:\/\/www.enago.com\/academy","author_name":"Dr. Shweta Murudkar","author_url":"https:\/\/www.enago.com\/academy\/author\/shwetad\/","title":"Pharmacovigilance Post COVID-19: Opportunities and Challenges - Enago Academy","type":"rich","width":600,"height":338,"html":"<blockquote class=\"wp-embedded-content\" data-secret=\"uys6tyb3Zk\"><a href=\"https:\/\/www.enago.com\/academy\/pharmacovigilance-post-covid-19-opportunities-and-challenges\/\">Pharmacovigilance Post COVID-19: Opportunities and Challenges<\/a><\/blockquote><iframe sandbox=\"allow-scripts\" security=\"restricted\" src=\"https:\/\/www.enago.com\/academy\/pharmacovigilance-post-covid-19-opportunities-and-challenges\/embed\/#?secret=uys6tyb3Zk\" width=\"600\" height=\"338\" title=\"&#8220;Pharmacovigilance Post COVID-19: Opportunities and Challenges&#8221; &#8212; Enago Academy\" data-secret=\"uys6tyb3Zk\" frameborder=\"0\" marginwidth=\"0\" marginheight=\"0\" scrolling=\"no\" class=\"wp-embedded-content\"><\/iframe><script type=\"text\/javascript\">\n\/* <![CDATA[ *\/\n\/*! This file is auto-generated *\/\n!function(d,l){\"use strict\";l.querySelector&&d.addEventListener&&\"undefined\"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!\/[^a-zA-Z0-9]\/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret=\"'+t.secret+'\"]'),o=l.querySelectorAll('blockquote[data-secret=\"'+t.secret+'\"]'),c=new RegExp(\"^https?:$\",\"i\"),i=0;i<o.length;i++)o[i].style.display=\"none\";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute(\"style\"),\"height\"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):\"link\"===t.message&&(r=new URL(s.getAttribute(\"src\")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener(\"message\",d.wp.receiveEmbedMessage,!1),l.addEventListener(\"DOMContentLoaded\",function(){for(var e,t,s=l.querySelectorAll(\"iframe.wp-embedded-content\"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute(\"data-secret\"))||(t=Math.random().toString(36).substring(2,12),e.src+=\"#?secret=\"+t,e.setAttribute(\"data-secret\",t)),e.contentWindow.postMessage({message:\"ready\",secret:t},\"*\")},!1)))}(window,document);\n\/* ]]> *\/\n<\/script>\n","thumbnail_url":"https:\/\/www.enago.com\/academy\/wp-content\/uploads\/2020\/09\/Pharmacovigilance-post-pandemic.jpg","thumbnail_width":750,"thumbnail_height":430,"description":"The COVID-19 pandemic has highlighted the need for a more rigorous and robust pharmacovigilance system. The ongoing pandemic has not only affected how clinical trials are conducted but also impacted data collection, analysis, and reporting. It is imperative to have a strategy in place to tackle this crisis!"}